The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

The Effects of Phragmitis Rhizoma Herbal-acupuncture Solution on Inflammation in Human Mast Cells and Human Alveolar Epithelial Cell Lines - Phragmitis Rhizoma's Effects -

  • Received : 2014.10.08
  • Accepted : 2014.11.05
  • Published : 2014.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was designed to find the effect of Phragmitis Rhizoma (PR) herbal-acupuncture solution on the inflammatory cytokine and chemokine secretion in human mast cell (HMC) and human alveolar epithelial cell 549 (A549) lines. Methods: Histamine levels in HMC after PR herbal-acupuncture solution treatment were measured with ELISA. Other cytokines and chemokines levels such as interleukin 8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and chemokine (C-C motif) ligand 5 (Ccl5, RANTES) in A549 were measured with flow cytometry CBA system. Results: In the PR herbal-acupuncture solution treatment group, the expression of histamine, IL-8, MPC-1, Ccl5, and RANTES decreased significantly. Conclusions: The results support that PR herbal-acupuncture solution had a suppressive effect on cytokine-induced inflammation.

Keywords

References

  1. Kim IR, Kim HC, Kook YB, Park SJ, Park YG, Park JH, et al. Boncho-Hak. Seoul:Young-Lim Press. 2007:203-4.
  2. Lee WH. Effect of Phragmitis Rhizoma (PR) to Diabetes Mellitus of White Rat Induced by Streptozotocin. Kyung-san University Graduate School. 1983:1-33.
  3. Kim YS. An Immunohistological Study of Effect of Phragmitis Rhizoma (PR) to Streptozotocin Diabetes J. East-West Medicines. 1993;18(3):30-9.
  4. Choi JS, Chung HY, Young HS. A Preliminary Study on Hypocholesterolemic and Hypoglycemic Activities of Some Medicinal Plants. Kor. J. Pharmacogn. 1990;21(2):153-7
  5. Choi JS, Lee JH, Han SY. Anti-hyperlipidemic Effect of Phragmitis communis and its Active Principles. J. Kor. Soc. Food Nutr. 1995;24(4):523-9
  6. Jang KH, Roh SS. Depigementation activity of many herbs. Traditional Korean medicine questionnaires. 2004;13(2):289-302
  7. Yoon JH. Whitening Activity of Phenolic Compound from Phragmitis Phizoma. Jung-ang University Graduate School. Pharmacy Pharmacognosy a master's thesis. 2006:1-79.
  8. Gallin J, Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 3rd edition. Philadelphia:Lippincott William and Wilkins. 1999:1-4.
  9. Janeway C, Travers P, Walport M, Shlomchik M. Immunobiology. The immune system in Health and Disease. 4th edition. New York:Garland. 1999:1-30.
  10. Roitt I, Brostoff J, Male D. Immunology. 5th edition. London:Mosby. 2002:264-5.
  11. Available at: URL: http://en.wikipedia.org/wiki/Interleukin-6#cite_ref-2
  12. Shute J, Vrugt B, Lindley I, Holgate S, Bron A, Aalbers R, et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Resp Crit Care Med. 1997;155:1877-83. https://doi.org/10.1164/ajrccm.155.6.9196089
  13. Matsushima K, Larsen CGD, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocyte cell line. J Exp Med. 1998;169:1485-90.
  14. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein-1 acts as a T-lymphocyte. USA. Proc Natl Acad Sci. 1995;91:3652-56.
  15. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993;150:1932-43.
  16. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97:104-12. https://doi.org/10.1016/S0091-6749(96)70288-9
  17. Sousa AR, Lane S, Nakhostee JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol. 1994;10:142-47. https://doi.org/10.1165/ajrcmb.10.2.8110469
  18. Altman GB, Altman LC, Luchtel DL, Jabbour AJ, Baker C. Release of RANTES from nasal and bronchial epithelial cells. Cell Biology and Toxicology. 1997;13(3): 205-13. https://doi.org/10.1023/A:1007318514715
  19. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med. 1995;152:927-33. https://doi.org/10.1164/ajrccm.152.3.7545059
  20. Marone G, Granata F, Spadaro G, Genovese A, Triggiani M. The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol. 2003;112(4):83-8. https://doi.org/10.1016/S0091-6749(03)01881-5
  21. MacGlashan D Jr. Histamine: A mediator of inflammation. J Allergy Clin Immunol. 2003;112(4):53-9 https://doi.org/10.1016/S0091-6749(03)01877-3
  22. Weltman JK. Histamine as a regulator of allergic and asthmatic inflammation. Allergy Asthma Proc. 2003;24(4):227-9.
  23. Akdis CA, Blaser K. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol. 2003;112(1):15-22. https://doi.org/10.1067/mai.2003.1585